Rubicon, Kreatech Sign Amplification Tech Agreement | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rubicon Genomics has signed an agreement to provide Kreatech Diagnostics with its OmniPlex-D whole-genome amplification technology.

Under the agreement, Rubicon will provide Kreatech with reagents incorporating elements of the OmniPlex technology, which Kreatech will use in the manufacture of its Poseidon fluorescence in situ hybridization probes. Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.